Institution
Indian Institute of Technology Guwahati
Education•Guwahati, Assam, India•
About: Indian Institute of Technology Guwahati is a education organization based out in Guwahati, Assam, India. It is known for research contribution in the topics: Catalysis & Computer science. The organization has 6933 authors who have published 17102 publications receiving 257351 citations.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: This review has discussed most recent developments of portable diagnostic devices and wearable sensors based on the combined features of smartphones and biosensors for POC applications and their sensing mechanism using smartphones.
83 citations
••
TL;DR: The desulfurization ability of diacetoxyiodobenzene (DIB) has been explored in the preparation of isothiocyanates from the corresponding dithiocarbamate salts as discussed by the authors.
83 citations
••
TL;DR: In this paper, Collins asymmetries in the inclusive process e^+e^−→ππX, where π stands for charged pions, at a center-of-mass energy of 10.6 GeV, were investigated.
Abstract: We present measurements of Collins asymmetries in the inclusive process e^+e^−→ππX, where π stands for charged pions, at a center-of-mass energy of 10.6 GeV. We use a data sample of 468 fb^(−1) collected by the BABAR experiment at the PEP-II B factory at SLAC, and consider pairs of charged pions produced in opposite hemispheres of hadronic events. We observe clear asymmetries in the distributions of the azimuthal angles in two distinct reference frames. We study the dependence of the asymmetry on several kinematic variables, finding that it increases with increasing pion momentum and momentum transverse to the analysis axis, and with increasing angle between the thrust and beam axis.
83 citations
••
TL;DR: This paper proposes a Route Stability based QoS Routing (RSQR) protocol in Mobile Ad Hoc Networks (MANETs) which is an extension of QoS routing with throughput and delay constraints which shows performance improvements in terms of packet delivery ratio, control overhead and average end-to-end delay.
Abstract: To provide high quality communications service among mobile wireless devices is basically a challenging task in wireless ad hoc networks. In this paper, we propose a Route Stability based QoS Routing (RSQR) protocol in Mobile Ad Hoc Networks (MANETs) which is an extension of QoS routing with throughput and delay constraints. Ensuring a data path to be valid for sufficiently longer period of time is a very difficult problem in MANET due to its highly dynamic nature. We propose a simple model for computing link stability and route stability based on received signal strengths. By including some extra fields in route request/reply packets, the route stability information can be utilized to select a route with higher stability among all the feasible routes between a given source destination pair. Further, inclusion of a signal strength based admission control enhances the performance of the routing. Results of our experiments show performance improvements in terms of packet delivery ratio, control overhead and average end-to-end delay in comparison with a QoS routing protocol proposed by Q. Xue and A. Ganz.
83 citations
••
TL;DR: The expression, function, and possible use of CD90 in different cancers and its possible use as a biomarker or a therapeutic target in cancer are summarized.
Abstract: THY1 (CD90) is a 25–37-kDa heavily N-glycosylated, glycophosphatidylinositol (GPI) anchored cell surface protein. It is usually expressed on thymocytes, mesenchymal stem cells, hematopoietic stem cells, natural killer cells, neurons, endothelial cells, renal glomerular mesangial cells, follicular dendritic cells, fibroblasts, and myofibroblasts. It has been found to regulate cell adhesion, migration, apoptosis, axon growth, cell-cell and cell-matrix interactions, T-cell activation, and fibrosis. Several reports have shown that CD90 has an important role in cancer in regulating cancer cell proliferation, metastasis, and angiogenesis. There are also evidences that CD90 is an important prognostic marker in many cancers. Consequently, therapies that target CD90 have great promise in treating many cancers. However, several studies also indicate a contradictory role for CD90, where it acts as a tumor suppressor. In this review, we summarize the expression, function of CD90 in different cancers and its possible use as a biomarker or a therapeutic target in cancer. The challenges and future prospects for the use of CD90 for clinical applications are also discussed in this review.
82 citations
Authors
Showing all 7128 results
Name | H-index | Papers | Citations |
---|---|---|---|
Jasvinder A. Singh | 176 | 2382 | 223370 |
Dipanwita Dutta | 143 | 1651 | 103866 |
Sanjay Gupta | 99 | 902 | 35039 |
Santosh Kumar | 80 | 1196 | 29391 |
Subrata Ghosh | 78 | 841 | 32147 |
Rishi Raj | 78 | 569 | 22423 |
B. Bhuyan | 73 | 658 | 21275 |
Ravi Shankar | 66 | 672 | 19326 |
Ashutosh Sharma | 66 | 570 | 16100 |
Gautam Biswas | 63 | 721 | 16146 |
Sam P. de Visser | 62 | 256 | 13820 |
Surendra Nadh Somala | 61 | 144 | 28273 |
Manish Kumar | 61 | 1425 | 21762 |
Mihir Kumar Purkait | 57 | 267 | 9812 |
Ajaikumar B. Kunnumakkara | 57 | 201 | 20025 |